Michael Campbell, Ph.D.
Manager of Radiopharmacy Operations
Education:
- BSc Chemistry, University of New Brunswick
- PhD Chemistry, University of Waterloo
Appointments and Affiliations:
- Adjunct Professor, Department of Chemistry, Lakehead University; 2008– present
- Lecturer, Department of Chemistry, Lakehead University; 2007 – 2008
- Post Doct oral Fellowship, Duke University (Michael Pirrung)
Industrial Positions:
- Principal Scientist, Medicinal Chemistry (2005-2006) and Associate Director, Medicinal Chemistry (2006-2007), AtheroGenics Inc., Alpharetta GA.
- Senior Scientist (2003 – 2004) and Group Leader, Medicinal Chemistry (2004 – 2005), Athersys Inc., Cleveland OH.
- Scientist (1998 – 2000) and Senior Scientist (2000-2003), PPD Discovery Inc., Morrisville NC.
Research Areas of Focus:
- Development of new PET labeled biomarkers for molecular imaging in oncology and CNS
- Improvement of current synthetic route to existing radio-labeled biomarkers.
- Development of labels and labeling methods for use in 19F MR imaging.
- Development of new PET / Cyclotron targets.
- Methods for predicting the clinical effectiveness of an oncology drug using PET
Michael Campbell - Profile (PDF)
